Organigram Global (OGI) Cash & Equivalents (2018 - 2026)
Organigram Global (OGI) posted quarterly Cash & Equivalents of $3.1 million for Q1 2026, down 42.39% quarter-over-quarter from $5.4 million in Q4 2025.
Organigram Global (OGI) Cash & Equivalents (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Cash & Equivalents for 9 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents changed N/A year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (changed N/A YoY), while the FY2025 annual figure was $5.4 million, changed N/A from the prior year.
- Cash & Equivalents eased to $3.1 million in Q1 2026 per OGI's latest filing, from $5.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $97.2 million in Q3 2024 and bottomed at $3.1 million in Q1 2026.
- Historically, Cash & Equivalents has averaged $30.9 million across 5 years, with a median of $20.7 million in 2022.
- Annual changes were most pronounced in 2024 — Cash & Equivalents surged 151.78% — and 2025, when it plunged 78.92%.
- Organigram Global's Cash & Equivalents stood at $20.8 million in 2022, then jumped by 85.38% to $38.6 million in 2023, then soared by 151.78% to $97.2 million in 2024, then tumbled by 94.41% to $5.4 million in 2025, then plunged by 42.39% to $3.1 million in 2026.
- Business Quant data shows OGI's Cash & Equivalents at $3.1 million in Q1 2026, $5.4 million in Q4 2025, and $20.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 164.00 Mn |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn | 3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 20.49 Mn |
| Sep 30, 2024 | 97.21 Mn |
| Sep 30, 2023 | 38.61 Mn |
| Aug 31, 2022 | 20.83 Mn |
| Nov 30, 2021 | 687,000.00 |
| Aug 31, 2021 | 55.37 Mn |
| May 31, 2021 | -31.11 Mn |
| Feb 28, 2021 | 61.12 Mn |
| Nov 30, 2020 | 103.90 Mn |
| Aug 31, 2020 | 5.98 Mn |
| May 31, 2020 | 31.92 Mn |
| Feb 29, 2020 | 41.09 Mn |
| May 31, 2019 | 47.19 Mn |
| Aug 31, 2018 | 55.06 Mn |